These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of a somatostatin analogue in association with surgery and hepatic arterial embolisation in the treatment of the carcinoid syndrome. Ahlman H; Ahlund L; Dahlström A; Nilsson O; Skolnik G; Tisell LE; Tylén U Br J Cancer; 1987 Dec; 56(6):840-2. PubMed ID: 2893640 [No Abstract] [Full Text] [Related]
5. [Somatostatin analogs in the treatment of carcinoid syndrome: a case report and review of literature]. Junik R; Kamińska A; Kamiński M; Ruprecht Z Pol Arch Med Wewn; 2003 Sep; 110(3):997-1001. PubMed ID: 14699693 [TBL] [Abstract][Full Text] [Related]
6. [Hepatic artery embolization for treatment of the carcinoid syndrome]. Meves M; Abdelhamid S; Wollenweber J Z Gastroenterol; 1982 Aug; 20(8):438-47. PubMed ID: 7136127 [TBL] [Abstract][Full Text] [Related]
7. [Effect of somatostatin and salmon calcitonin on carcinoid syndrome. A clinical case]. Festa V; Garrone C; Vietti Ramus G; Lisa F; Simone P; Scotti M; Cocchis D; Garrone GC Minerva Chir; 1989 May; 44(9):1429-33. PubMed ID: 2569698 [TBL] [Abstract][Full Text] [Related]
8. Effects of somatostatin on bronchial constriction in a patient with carcinoid syndrome. Klapdor R N Engl J Med; 1980 Aug; 303(8):464. PubMed ID: 6104790 [No Abstract] [Full Text] [Related]
9. Carcinoid syndrome treated by hepatic embolization. Pueyo I; Jiménez JR; Hernández J; Brugarolas A; García-Morán M; García-Muñiz JL; Arroyo F AJR Am J Roentgenol; 1978 Sep; 131(3):511-3. PubMed ID: 99001 [No Abstract] [Full Text] [Related]
10. Successful symptomatic treatment of malignant carcinoid syndrome with the somatostatin analogue SMS 201-995. van Houten AA; Nortier JW; Vendrik CP Neth J Med; 1988 Apr; 32(3-4):194-8. PubMed ID: 2896307 [No Abstract] [Full Text] [Related]
11. Catecholamines and the carcinoid syndrome. Cross MH Anaesthesia; 1993 Jan; 48(1):81-2. PubMed ID: 8094603 [No Abstract] [Full Text] [Related]
12. The carcinoid syndrome. Oates JA N Engl J Med; 1986 Sep; 315(11):702-4. PubMed ID: 2875390 [No Abstract] [Full Text] [Related]
13. Rapid reversal of carcinoid crisis with a somatostatin analogue. Kvols LK; Martin JK; Marsh HM; Moertel CG N Engl J Med; 1985 Nov; 313(19):1229-30. PubMed ID: 2865675 [No Abstract] [Full Text] [Related]
14. Effects of somatostatin infusion in four patients with malignant carcinoid syndrome. Quatrini M; Basilisco G; Conte D; Bozzani A; Bardella MT; Bianchi PA Am J Gastroenterol; 1983 Mar; 78(3):149-51. PubMed ID: 6187212 [TBL] [Abstract][Full Text] [Related]
15. [Carcinoid syndrome]. Li D; Cheng Y Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):246-8. PubMed ID: 7587683 [No Abstract] [Full Text] [Related]
16. Carcinoid Flush: role of gastrin and somatostatin. N Engl J Med; 1979 Mar; 300(11):624. PubMed ID: 763277 [No Abstract] [Full Text] [Related]
17. An update of lanreotide acetate for treatment of adults with carcinoid syndrome. Guadalupe E; Deshpande HA; Stein SM Drugs Today (Barc); 2018 Aug; 54(8):457-465. PubMed ID: 30209440 [TBL] [Abstract][Full Text] [Related]
18. New Treatments for the Carcinoid Syndrome. Loughrey PB; Zhang D; Heaney AP Endocrinol Metab Clin North Am; 2018 Sep; 47(3):557-576. PubMed ID: 30098716 [TBL] [Abstract][Full Text] [Related]
19. [Therapy of carcinoid and the carcinoid syndrome]. Rasenack U; Caspary W Dtsch Med Wochenschr; 1983 Apr; 108(17):671-3. PubMed ID: 6188602 [No Abstract] [Full Text] [Related]